221 related articles for article (PubMed ID: 15569926)
1. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis.
Gao H; Ouyang X; Banach-Petrosky W; Borowsky AD; Lin Y; Kim M; Lee H; Shih WJ; Cardiff RD; Shen MM; Abate-Shen C
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17204-9. PubMed ID: 15569926
[TBL] [Abstract][Full Text] [Related]
2. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795
[TBL] [Abstract][Full Text] [Related]
3. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
4. Genetic rescue of cell number in a mouse model of microphthalmia: interactions between Chx10 and G1-phase cell cycle regulators.
Green ES; Stubbs JL; Levine EM
Development; 2003 Feb; 130(3):539-52. PubMed ID: 12490560
[TBL] [Abstract][Full Text] [Related]
5. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.
Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G
Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620
[TBL] [Abstract][Full Text] [Related]
6. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
Sui L; Tokuda M; Ohno M; Hatase O; Hando T
Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
[TBL] [Abstract][Full Text] [Related]
7. [Effect of allitridi on cyclin D1 and p27(Kip1) protein expression in gastric carcinoma BGC823 cells].
Lan H; Lu YY
Ai Zheng; 2003 Dec; 22(12):1268-71. PubMed ID: 14693049
[TBL] [Abstract][Full Text] [Related]
8. p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process.
Taylor W; Mathias A; Ali A; Ke H; Stoynev N; Shilkaitis A; Green A; Kiyokawa H; Christov K
BMC Cancer; 2010 Oct; 10():541. PubMed ID: 20932324
[TBL] [Abstract][Full Text] [Related]
9. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants.
Ewton DZ; Lee K; Deng X; Lim S; Friedman E
Int J Cancer; 2003 Jan; 103(1):21-8. PubMed ID: 12455049
[TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
11. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
12. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
13. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
14. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
[TBL] [Abstract][Full Text] [Related]
15. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression.
Graff JR; Konicek BW; McNulty AM; Wang Z; Houck K; Allen S; Paul JD; Hbaiu A; Goode RG; Sandusky GE; Vessella RL; Neubauer BL
J Biol Chem; 2000 Aug; 275(32):24500-5. PubMed ID: 10827191
[TBL] [Abstract][Full Text] [Related]
16. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
[TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
[TBL] [Abstract][Full Text] [Related]
18. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
19. Methylation and mutational analysis of p27(kip1) in prostate carcinoma.
Kibel AS; Christopher M; Faith DA; Bova GS; Goodfellow PJ; Isaacs WB
Prostate; 2001 Sep; 48(4):248-53. PubMed ID: 11536304
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
